Indogulf Cropsciences Ltd
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]
- Market Cap ₹ 345 Cr.
- Current Price ₹ 54.6
- High / Low ₹ 112 / 49.5
- Stock P/E 9.11
- Book Value ₹ 72.6
- Dividend Yield 0.00 %
- ROCE 11.9 %
- ROE 10.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.75 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 8.81% over past five years.
- Company has a low return on equity of 12.0% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of Nifty IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 492 | 443 | 486 | 551 | 553 | 592 | 676 | 653 | |
| 457 | 404 | 442 | 501 | 493 | 528 | 605 | 582 | |
| Operating Profit | 35 | 39 | 45 | 49 | 60 | 64 | 71 | 71 |
| OPM % | 7% | 9% | 9% | 9% | 11% | 11% | 10% | 11% |
| 3 | 2 | 4 | 1 | -2 | 6 | 8 | 9 | |
| Interest | 5 | 5 | 6 | 11 | 12 | 14 | 17 | 17 |
| Depreciation | 5 | 6 | 8 | 8 | 9 | 10 | 11 | 12 |
| Profit before tax | 28 | 31 | 36 | 31 | 36 | 45 | 51 | 51 |
| Tax % | 28% | 26% | 26% | 26% | 21% | 29% | 25% | |
| 20 | 23 | 26 | 23 | 29 | 32 | 39 | 38 | |
| EPS in Rs | 52.30 | 9.77 | 11.26 | 9.80 | 12.19 | 6.58 | 6.11 | 6.00 |
| Dividend Payout % | 10% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 7% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 19% |
| TTM: | 24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -48% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 24 | 24 | 24 | 24 | 49 | 63 |
| Reserves | 127 | 131 | 157 | 180 | 209 | 228 | 396 |
| 92 | 79 | 102 | 189 | 155 | 222 | 177 | |
| 150 | 178 | 139 | 121 | 154 | 183 | 177 | |
| Total Liabilities | 373 | 411 | 421 | 513 | 541 | 682 | 813 |
| 47 | 51 | 53 | 65 | 44 | 47 | 48 | |
| CWIP | 4 | 6 | 9 | 9 | 22 | 57 | 76 |
| Investments | 3 | 3 | 0 | 0 | 0 | 0 | 12 |
| 319 | 352 | 359 | 440 | 474 | 578 | 678 | |
| Total Assets | 373 | 411 | 421 | 513 | 541 | 682 | 813 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -17 | 20 | -9 | 31 | 36 | -12 | -41 | |
| -35 | -10 | -10 | 0 | 0 | -40 | -36 | |
| 52 | -9 | 20 | 0 | 0 | 58 | 79 | |
| Net Cash Flow | 0 | 1 | 0 | 31 | 36 | 6 | 3 |
| Free Cash Flow | -52 | 10 | -21 | 31 | 36 | -52 | -69 |
| CFO/OP | -25% | 71% | 1% | 63% | 61% | 0% | -39% |
Ratios
Standalone / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 97 | 115 | 117 | 146 | 140 | 124 |
| Inventory Days | 154 | 205 | 167 | 201 | 195 | 229 | 248 |
| Days Payable | 96 | 138 | 111 | 79 | 109 | 116 | 97 |
| Cash Conversion Cycle | 147 | 164 | 171 | 239 | 231 | 253 | 274 |
| Working Capital Days | 51 | 62 | 86 | 94 | 114 | 114 | 149 |
| ROCE % | 16% | 16% | 12% | 13% | 13% | 12% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| New Product Launches count |
|
||||
| Capacity Utilization % |
|||||
| Distributors (B2C) count |
|||||
| Export Countries count |
|||||
| Institutional Business Partners (B2B) count |
|||||
| Product Registrations count |
|||||
| Products Portfolio count |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approved director reappointment, secretarial auditor appointment, and IPO proceeds variation/extension for Barwasani expansion.
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approved director reappointment, secretarial auditor appointment, and IPO proceeds variation with utilization extension.
-
Closure of Trading Window
- Trading window closed from October 1, 2026 for Q2 FY27 unaudited results.
- Scrutinizer'S Report And Voting Results Of The 34Th Annual General Meeting Of The Company Held On September 24, 2026
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 34th AGM held September 24, 2026; shareholders approved IPO proceeds variation and extension, plus director reappointment.
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026PPT
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.